» Articles » PMID: 17207788

Time-dependent Involvement of CAMP and CGMP in Consolidation of Object Memory: Studies Using Selective Phosphodiesterase Type 2, 4 and 5 Inhibitors

Overview
Journal Eur J Pharmacol
Specialty Pharmacology
Date 2007 Jan 9
PMID 17207788
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

The present study investigated the time-dependent memory enhancing properties of three selective phosphodiesterase inhibitors (PDE-I) vardenafil (PDE5-I), rolipram (PDE4-I) and BAY 60-7550 (PDE2-I) in the object recognition task. In particular, the time-dependent involvement of cAMP and cGMP in memory consolidation was assessed by altering the time points of drug administration. Vardenafil (1 mg/kg, p.o.), rolipram (0.03 mg/kg, i.p.), and BAY 60-7550 (3 mg/kg, p.o.) were tested in rats with a 24 h delay between the learning and the test trial. The PDE-Is were administered at different time points, i.e. directly after, 1 h, 3 h and 6 h after the first trial. Using a 24 h interval, vardenafil only showed an effect on object memory when injected directly after trial 1, rolipram only showed an improvement when injected 3 h after trial 1 and BAY 60-7550 improved memory when injected either directly after or 3 h after trial 1. No treatment effects were found when the compounds were administered 1 h or 6 h after the first trial. Our results extend our previous data that different types of PDE-Is affect different stages of memory consolidation. Moreover, the present study provides further support that selective PDE-Is can influence memory consolidation in a time-dependent manner, assumingly by elevating central cAMP and cGMP levels.

Citing Articles

Longevity, enhanced memory, and altered density of dendritic spines in hippocampal CA3 and dentate gyrus after hemizygous deletion of Pde2a in mice.

Baumgartel K, Broadbent N, Su H, Masatsugu B, Maruyama K, Johnson R Neuropsychopharmacology. 2024; .

PMID: 39604498 DOI: 10.1038/s41386-024-02031-w.


Sildenafil prevents chronic psychosocial stress-induced working memory impairment: Role of brain-derived neurotrophic factor.

Jibril T, Alzoubi K, Mhaidat N, Khabour O, Alqudah M, Rababah A Curr Res Pharmacol Drug Discov. 2024; 6:100182.

PMID: 38706525 PMC: 11067328. DOI: 10.1016/j.crphar.2024.100182.


A case-control study of phosphodiesterase-5 inhibitor use and Alzheimer's disease and related dementias among male and female patients aged 65 years and older supporting the need for a phase III clinical trial.

Henry D, Pellegrino R PLoS One. 2023; 18(10):e0292863.

PMID: 37851623 PMC: 10584171. DOI: 10.1371/journal.pone.0292863.


Virtual Screening-Accelerated Discovery of a Phosphodiesterase 9 Inhibitor with Neuroprotective Effects in the Kainate Toxicity In Vitro Model.

Landucci E, Ribaudo G, Anyanwu M, Oselladore E, Giannangeli M, Mazzantini C ACS Chem Neurosci. 2023; 14(20):3826-3838.

PMID: 37726213 PMC: 10587872. DOI: 10.1021/acschemneuro.3c00431.


EXPLORE: a novel deep learning-based analysis method for exploration behaviour in object recognition tests.

Ibanez V, Bohlen L, Manuella F, Mansuy I, Helmchen F, Wahl A Sci Rep. 2023; 13(1):4249.

PMID: 36918658 PMC: 10014875. DOI: 10.1038/s41598-023-31094-w.